IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $704 | -6.6% | 37,135 | -23.6% | 0.01% | 0.0% |
| Q1 2023 | $754 | -99.4% | 48,595 | +113.4% | 0.01% | +200.0% |
| Q3 2022 | $127,000 | -89.6% | 22,776 | -92.7% | 0.00% | -86.7% |
| Q2 2022 | $1,222,000 | -25.6% | 313,356 | +5.1% | 0.02% | -28.6% |
| Q1 2022 | $1,642,000 | -4.1% | 298,070 | +48.3% | 0.02% | +16.7% |
| Q4 2021 | $1,713,000 | +47.9% | 201,044 | +50.9% | 0.02% | +12.5% |
| Q3 2021 | $1,158,000 | -59.8% | 133,200 | -51.2% | 0.02% | -50.0% |
| Q2 2021 | $2,882,000 | +732.9% | 272,717 | +1151.0% | 0.03% | +433.3% |
| Q4 2019 | $346,000 | – | 21,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |